Filters close
Released: 9-Nov-2011 9:30 AM EST
New Long-Term Data on VIVITROL Showed Sustained Efficacy and Safety Over 18 Months of Treatment
Alkermes plc

Alkermes plc (NASDAQ: ALKS) today presented positive results from a long-term study of VIVITROL® (naltrexone for extended-release injectable suspension) at the 24th Annual U.S. Psychiatric and Mental Health Congress in Las Vegas, NV. Results from the one-year, open-label extension of the six-month pivotal study showed sustained efficacy of VIVITROL, as measured by the number of opioid-free urine screens, in patients who received VIVITROL, in combination with psychosocial treatment, for a total of 18 months of treatment. Additionally, all safety events observed during the open-label extension were consistent with those set forth in the approved product labeling.

Released: 8-Feb-2011 9:00 AM EST
“The Five Things Every American Needs to Do to Lower Their Cholesterol” Revealed
Procter & Gamble

Metamucil and Dr. Michael Roizen, Chairman of the Wellness Institute at Cleveland Clinic and host of the upcoming PBS series, “Younger You,” have joined to present the “Five Things Every American Needs to Do to Lower Their Cholesterol” to encourage Americans to lead a proactive lifestyle with small modifications and dietary changes.

Released: 3-Feb-2009 7:00 AM EST
The International Scientific Association for Probiotics and Prebiotics Unveils New Consumer Guidelines
MS&L Group, New York

The International Scientific Association for Probiotics and Prebiotics (ISAPP) unveiled new guidelines to help consumers select credible probiotic and prebiotic products.

Released: 25-Aug-2008 8:00 AM EDT
New Study Shows Health Benefits of Probiotic Could Extend Beyond Gastrointestinal System
Alimentary Health

Data from a recent study demonstrate the anti-inflammatory and pathogen protection benefits of Bifidobacterium infantis 35624 a probiotic bacterial strain of human origin. Gastrointestinal benefits of probiotics have been well-documented, but more and more research is revealing that probiotic benefits extend to the entire body. The report was published in the August issue of the Public Library of Science (PLoS) Pathogens.

Released: 30-Jul-2008 8:00 AM EDT
Experts Continue to Cite Bifantis As Promising Probiotic Treatment for Irritable Bowel Syndrome
MS&L Group, New York

Two new review articles that cover therapeutic approaches to irritable bowel syndrome (IBS) in the July issue of Nutrition in Clinical Practice, cite growing evidence that probiotics, and specifically Bifidobacterium infantis 35624 (Bifantis), are effective in helping manage IBS. Both articles point to data that suggest Bifantis (available in the U.S. only in supplement form, marketed as Align) "“ has anti-inflammatory properties that help normalize gut function at a cellular level.

Released: 5-Dec-2007 8:00 AM EST
Procter & Gamble Pharmaceuticals

Findings reinforce the benefits of Asacol for ulcerative colitis patients.

Released: 15-Oct-2007 8:00 AM EDT
Only Bifantis Able to Claim Efficacy versus Placebo for IBS Symptoms
Alimentary Health

Researchers at the University of Michigan conducted an analysis of probiotics in the treatment of irritable bowel syndrome (IBS) and found that Bifantis, Bifidobacterium infantis 35624, the sole ingredient in Align, is the only probiotic currently able to demonstrate significant improvement in IBS symptoms based upon a properly designed research study.

21-May-2007 8:15 AM EDT
New Data On the Probiotic Strain Bifantis
Alimentary Health

The biotechnology company Alimentary Health today announced results from two studies that demonstrate the anti-inflammatory activity of a natural probiotic bacterial strain of human origin, Bifantis (Bifidobacterium infantis 35624), in models of arthritis and Salmonella infection. Data from these studies were presented this week at the 38th annual Digestive Disease Week (DDW) conference taking place in Washington D.C.

Released: 26-Oct-2006 5:55 PM EDT

Christopher Kennedy Lawford today announced his new role in helping to educate America about hepatitis C. Lawford, an accomplished author/actor and nephew of President John F. Kennedy, is sharing his experience in being diagnosed and successfully treated for hepatitis C as part of a national education campaign called Hep C STAT! (Stop, Test And Treat).

Released: 26-Oct-2006 3:10 PM EDT
Women’s Skin Tone Influences Perception of Beauty, Health, Age
MS&L Group, New York

The study, published in the latest issue of the journal Evolution and Human Behavior, used three-dimensional imaging and morphing software to remove wrinkles and furrows from pictures of women, leaving skin tone as the only variable. Researchers were then able to determine exactly what impact facial skin tone has on how young, healthy and attractive people perceive the women to be.

Released: 30-Jun-2006 4:15 PM EDT
Science Finds New Fix for UV Damaged Skin in Arthritis Treatment
MS&L Group, New York

New research indicates that glucosamine - a compound best known for treating arthritis "“ can actually help stop the formation of new age spots, and help fade existing ones.

Released: 16-Nov-2000 12:00 AM EST
Roche Global Development & Roche Bioscience

Roche Bioscience announced the successful validation of a novel mouse genotyping tool. This genotyping tool is expected to speed the development of new diagnostic and treatment agents from genomic research.

Released: 2-Nov-2000 12:00 AM EST
Key to Some Bladder Problems Found

Researchers from California and London have identified a previously unknown mechanism that controls the storage capacity of the bladder and the frequency of urination. (Nature, 10-26-00)

Showing results 1 – 13 of 13